Shize Yang

467 total citations
18 papers, 344 citations indexed

About

Shize Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Shize Yang has authored 18 papers receiving a total of 344 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 8 papers in Cancer Research. Recurrent topics in Shize Yang's work include RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (4 papers). Shize Yang is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer-related molecular mechanisms research (5 papers) and Circular RNAs in diseases (4 papers). Shize Yang collaborates with scholars based in China and United States. Shize Yang's co-authors include Siyuan Dong, Xinwen Zhong, Xiaohan Qu, Xitao Chen, Pei-Wen Li, Lin Zhang, Wenya Li, Zhenghua Liu, Shun Xu and Siyu Zhou and has published in prestigious journals such as ACS Catalysis, Journal of Hematology & Oncology and Frontiers in Oncology.

In The Last Decade

Shize Yang

18 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shize Yang China 10 265 198 89 60 28 18 344
Hai‐Liang Zhang China 10 319 1.2× 315 1.6× 132 1.5× 53 0.9× 20 0.7× 15 441
Chuanchao He China 12 295 1.1× 166 0.8× 50 0.6× 71 1.2× 42 1.5× 21 411
Dorothee Franziska Strohmer China 5 174 0.7× 110 0.6× 100 1.1× 98 1.6× 21 0.8× 6 309
Jinyu Xiang China 11 266 1.0× 126 0.6× 57 0.6× 94 1.6× 14 0.5× 20 357
Wenxuan Xie China 10 231 0.9× 182 0.9× 91 1.0× 85 1.4× 37 1.3× 22 367
Wanli Ge China 12 309 1.2× 251 1.3× 36 0.4× 83 1.4× 19 0.7× 18 392
Zhiqi Yao China 4 260 1.0× 276 1.4× 38 0.4× 71 1.2× 21 0.8× 4 383
Weijian Guo China 6 214 0.8× 157 0.8× 73 0.8× 85 1.4× 12 0.4× 9 305
Lulin Cheng China 9 219 0.8× 162 0.8× 116 1.3× 54 0.9× 33 1.2× 13 323
Zhicheng Yu China 10 207 0.8× 168 0.8× 76 0.9× 50 0.8× 21 0.8× 22 320

Countries citing papers authored by Shize Yang

Since Specialization
Citations

This map shows the geographic impact of Shize Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shize Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shize Yang more than expected).

Fields of papers citing papers by Shize Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shize Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shize Yang. The network helps show where Shize Yang may publish in the future.

Co-authorship network of co-authors of Shize Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Shize Yang. A scholar is included among the top collaborators of Shize Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shize Yang. Shize Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Qingju, Meijia Li, Darren M. Driscoll, et al.. (2025). Mesoporous Amorphous High-Entropy Oxide Films: Unlocking Enhanced Redox Activity. ACS Catalysis. 15(13). 11806–11817. 1 indexed citations
2.
Yu, Honghao, et al.. (2025). Repair mechanisms of bone system tissues based on comprehensive perspective of multi-omics. Cell Biology and Toxicology. 41(1). 45–45. 3 indexed citations
3.
4.
Wang, Yizi, Bin Ma, Shize Yang, Wenya Li, & Peiwen Li. (2022). Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett’s Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials. Frontiers in Oncology. 12. 801940–801940. 4 indexed citations
5.
Luo, Ji, Shize Yang, & Siyuan Dong. (2021). Selective Mediastinal Lymphadenectomy or Complete Mediastinal Lymphadenectomy for Clinical Stage I Non-Small Cell Lung Cancer: A Meta-Analysis. Advances in Therapy. 38(12). 5671–5683. 7 indexed citations
6.
7.
Liu, Zhenghua, et al.. (2021). Prognostic Value of lncRNA DRAIC and miR-3940-3p in Lung Adenocarcinoma and Their Effect on Lung Adenocarcinoma Cell Progression. Cancer Management and Research. Volume 13. 8367–8376. 8 indexed citations
8.
Yang, Shize, et al.. (2021). High expression of MCM10 is predictive of poor outcomes in lung adenocarcinoma. PeerJ. 9. e10560–e10560. 5 indexed citations
9.
10.
Chen, Shuang, Shize Yang, Shun Xu, & Siyuan Dong. (2020). Comparison between radiofrequency ablation and sublobar resections for the therapy of stage I non-small cell lung cancer: a meta-analysis. PeerJ. 8. e9228–e9228. 7 indexed citations
11.
Dong, Siyuan, et al.. (2020). CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma. PeerJ. 8. e10126–e10126. 10 indexed citations
12.
Dong, Siyuan, et al.. (2020). Identification of lung adenocarcinoma biomarkers based on bioinformatic analysis and human samples. Oncology Reports. 43(5). 1437–1450. 19 indexed citations
13.
Zou, Fangwen, Shize Yang, Wenya Li, et al.. (2020). circRNA_001275 upregulates Wnt7a expression by competitively sponging miR‑370‑3p to promote cisplatin resistance in esophageal cancer. International Journal of Oncology. 57(1). 151–160. 24 indexed citations
14.
Dong, Siyuan, Steven A. Roberts, Shuang Chen, et al.. (2019). Survival after lobectomy versus sub-lobar resection in elderly with stage I NSCLC: a meta-analysis. BMC Surgery. 19(1). 38–38. 9 indexed citations
15.
Qu, Xiaohan, et al.. (2019). RFC3 induces epithelial‑mesenchymal transition in lung adenocarcinoma cells through the Wnt/β‑catenin pathway and possesses prognostic value in lung adenocarcinoma. International Journal of Molecular Medicine. 44(6). 2276–2288. 21 indexed citations
16.
Yang, Shize, et al.. (2016). Clinical significance of Wip1 overexpression and its association with the p38MAPK/p53/p16 pathway in NSCLC. Molecular Medicine Reports. 15(2). 719–723. 14 indexed citations
17.
18.
Zhong, Xinwen, et al.. (2014). Examining Nek2 as a better proliferation marker in non-small cell lung cancer prognosis. Tumor Biology. 35(7). 7155–7162. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hai‐Liang Zhang Breakdown of academic impact, for papers by Chuanchao He Breakdown of academic impact, for papers by Dorothee Franziska Strohmer Breakdown of academic impact, for papers by Jinyu Xiang Breakdown of academic impact, for papers by Wenxuan Xie Breakdown of academic impact, for papers by Wanli Ge Breakdown of academic impact, for papers by Zhiqi Yao Breakdown of academic impact, for papers by Weijian Guo Breakdown of academic impact, for papers by Lulin Cheng Breakdown of academic impact, for papers by Zhicheng Yu
Rankless by CCL
2026